Meléndez LJJ

Idioma: Español
Referencias bibliográficas: 44
Paginas: 59-67
Archivo PDF: 254.09 Kb.

RESUMEN

La Pouchitis o Bolsitis, constituye la principal complicación de la proctocolectomía total restaurativa con reservorio Ileoanal. Alrededor de un 30% de los pacientes con CUCI van a llegar a requerir este u otro procedimiento quirúrgico como opción terapéutica. Se presenta con manifestaciones clínicas, endoscópicas e histológicas y responde llamativamente a cursos cortos de antibióticos. Solo un pequeño porcentaje de casos llegara a requerir terapias adicionales o procedimientos quirúrgicos.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RA, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow up in 102 ulcerative colitis patients. Am J Gastroenterol 2004; 99: 432-441

2. Barton, J.G., Paden, M.A., Lane, M. and Postier, R.G. (2001) Comparison of postoperative outcomes in ulcerative colitis and familial polyposis patients after ileoanal pouch operations. Am J Surg 182: 616–620.

3. Bastida G, Beltrán B. Ulcerative colitis in smokers, non-smokers and exsmokers. World J Gastroenterol. 2011 Jun 14;17(22):2740-7.

4. Belluzzi, A., Serrani, M., Roda, G., Bianchi, M. L., Castellani, L., Grazia, M., Rosati, G., Ugolini, G. and Roda, E. Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. Alimentary Pharmacology & Therapeutics 2010, 31: 228–232. doi: 10.1111/j.1365-2036.2009.04163.x

5. Calabrese, C., Fabbri, A., Gionchetti, P., Rizzello, F., Morselli, C., Liguori, G., Pogglioli, G., Campieri, M. and Febo, G. D. Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis. Alimentary Pharmacology & Therapeutics 2007, 25: 1311–1316. doi:10.1111/j.1365-2036.2007.03323.x

6. Calabrese C, Gionchetti P, Rizzello F, Liguori G, Gabusi V, Tambasco R, Poggioli G, Pierangeli F, Campieri M, Di Febo G. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther. 2008 May;27(9):759-64. Epub 2008 Feb 21.

7. Cheifetz A, Itzkowitz S. The diagnosis and treatment of pouchitis in inflammatory bowel disease. J Clin Gastroenterol. 2004 May-Jun;38(5 Suppl 1):S44-50.

8. Cima RR, Pemberton JH. Medical and surgical management of chronic ulcerative colitis. Arch Surg 2005; 140: 300-310

9. Duffy M, O’Mahony L, Coffey JC, et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 2002; 45: 384–8.

10. En-Da Yu, Zhuo Shao, Bo Shen. Pouchitis. World J Gastroenterol 2007 November 14; 13(42): 5598-5604

11. Ernesto Sierra-Montenegro, José Manuel Fernández-Rivero, Eduardo Villanueva- Sáenz, Juan Pablo Peña-Ruiz Esparza, Paulino Martínez-Hernández Magro, René Soto-Quirino. Calidad de vida después de proctocolectomía restaurativa con reservorio ileonal en “J” en pacientes con colitis ulcerativa. Cir Ciruj 2007;75:449-452

12. Fleshner PR, Vasiliauskas EA, Kam LY, Fleshner NE, Gaiennie J, Abreu- Martin MT, Targan SR. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001; 49: 671-677

13. Gionchetti, P., Rizzelo, F., Pogglioli, G., Pierangeli, F., Laureti, S., Morselli, C., Tambasco, R., Calabrese, C. and Campieri, M. Oral budesonide in the treatment of chronic refractory pouchitis. Alimentary Pharmacology & Therapeutics 2007, 25: 1231–1236. doi: 10.1111/j.1365-2036.2007.03306.x

14. Gosselink MP, Schouten WR, van Lieshout LM, Hop WC, Laman JD, Ruseler-van Embden JG. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum. 2004 Jun;47(6):876-84. Epub 2004 Apr 19.

15. Gosselink MP, Schouten WR, van Lieshout LM, Hop WC, Laman JD, Ruseler-van Embden JG. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum. 2004 Sep;47(9):1519-25. Epub 004 Jul 8.

16. Hahnloser, D., Pemberton, J. H., Wolff, B. G., Larson, D. R., Crownhart, B. S. and Dozois, R. R. (2007), Results at up to 20 years after ileal pouch–anal anastomosis for chronic ulcerative colitis. British Journal of Surgery, 94: 333–340. doi: 10.1002/bjs.5464

17. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497–500; discussion 501–2.

18. Kock NG, Darle N, Hulten L, et al. Ileostomy. Curr Probl Surg. 1977;14: 1–52.

19. Komanduri S, Gillevet PM, Sikaroodi M, Mutlu E, Keshavarzian A. Dysbiosis in pouchitis: evidence of unique microfl oral patterns in pouch infl ammation. Clin Gastroenterol Hepatol 2007; 5: 352-360

20. Lipman JM, Kiran RP, Shen B, Remzi F, Fazio VW. Perioperative factors during ileal pouch-anal anastomosis predict pouchitis. Dis Colon Rectum. 2011 Mar;54(3):311-7.

21. McLaughlin, S.D., Walker, A.W., Churcher, C., Clark, S.K., Tekkis, P.P., Johnson, M.W. et al. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16srRNA gene cloning and sequencing. Ann Surg 2010 Jul;252(1):90-8.

22. Merrett MN, Mortensen N, Kettlewell M, et al: Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut (1996) 38:362

23. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, Gionchetti P, Campieri M, Kamm MA. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004 Jan;53(1):108-14.

24. Nadgir RN, Soto JA, Dendrinos K, Lucey BC, Becker JM, Farraye FA. MRI of complicated pouchitis. AJR Am J Roentgenol 2006; 187: W386-W391

25. Nygaard K, Bergan T, Bjorneklett A, Hoverstad T, Lassen J, Aase S. Topical metronidazole treatment in pouchitis. Scand J Gastroenterol 1994; 29: 462–7.

26. Oikonomou I, Fazio VW, Remzi FH, Lopez R, Lashner BA, Shen B. Risk factors for anemia in patients with ileal pouchanal anastomosis. Dis Colon Rectum 2007; 50: 69-74

27. Pardi DS, D’Haens G, Shen B, Campbell S, Gionchetti P. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis. 2009 Sep;15(9):1424-31.

28. Pardi, D. S. and Sandborn, W. J. Systematic review: the management of pouchitis. Alimentary Pharmacology & Therapeutics, 2006; 23: 1087–1096. doi: 10.1111/j.1365-2036.2006.02884.x

29. Parks AG, Nichols RJ. Proctocolectomy without ileostomy for ulcerative colitis. BMJ. 1978;2:85-88.

30. Pastrana RJ, Torres EA, Arroyo JM, Rivera CE, Sanchez CJ, Morales L. Irondefi ciency anemia as presentation of pouchitis. J Clin Gastroenterol 2007; 41: 41-44

31. Penna C, Dozois R, Tremaine W, et al: Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut (1996) 38:234

32. Peter M. Mowschenson; Jonathan F. Critchlow; Mark A. Peppercorn. Ileoanal Pouch Operation: Long-term Outcome With or Without Diverting IleostomyArch Surg. 2000;135(4):463-466.

33. S.D. McLaughlin, S.K. Clark, P.P. Tekkis, R.J. Nicholls, and P.J. Ciclitira. The bacterial pathogenesis and treatment of pouchitis.Therapeutic Advances Gastroenterology November 2010 3: 335-348, first published on June 15, 2010 doi:10.1177/1756283X10370611

34. Sandborn, W.J. and Pardi, D.S. Clinical management of pouchitis. Gastroenterology 2004; 127: 1809–1814

35. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc. 1994 May;69(5):409-15.

36. Sehgal, Rishabh et al. “NOD2/CARD15 mutations correlate with severe pouchitis after ileal pouch-anal anastomosis.” Diseases of the colon and rectum 53.11 (2010) : 1487-1494.

37. Shen B, Achkar JP, Connor JT, Ormsby AH, Remzi FH, Bevins CL, Brzezinski A, Bambrick ML, Fazio VW, Lashner BA. Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum. 2003 Jun;46(6):748-53.

38. Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Bevins CL, Brzezinski A, Petras RE, Fazio VW. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology. 2001 Aug;121(2):261-7.

39. Shen, B., Achkar, J.P., Lashner, B. A., Ormsby, A. H., Remzi, F. H., Brzezinski, A., Bevins, C. L., Bambrick, M. L., Seidner, D. L. and Fazio, V. W. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflammatory Bowel Diseases 2001, 7: 301–305. doi: 10.1097/00054725-200111000-00004

40. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs. 2003;63(5):453-61.

41. Shen B, Fazio VW, Remzi FH, Bennett AE, Lopez R, Lavery IC, Brzezinski A, Sherman KK, Lashner BA. Effect of withdrawal of nonsteroidal antiinflammatory drug use on ileal pouch disorders. Dig Dis Sci. 2007 Dec;52(12):3321-8. Epub 2007 Apr 5.

42. Shen B, Fazio VW, Remzi FH, Delaney CP, Bennett AE, Achkar JP, Brzezinski A, Khandwala F, Liu W, Bambrick ML, Bast J, Lashner B. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol. 2005 Jan;100(1):93-101.

43. Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000; 24: 851–6.

44. Ståhlberg D, Gulberg K, Liljeqvist L, et al. Pouchitis following pelvic pouch operation for ulcerative colitis: incidence, cumulative risk, and risk factors. Dis Colon Rectum. 1996;39:1012–1018.